Effect of metal ion complexation and chalcogen donor identity on the antiproliferative activity of 2-acetylpyridine N,N-dimethyl(chalcogen)semicarbazones

Journal of Inorganic Biochemistry

Volumn 101, Issue 11-12, 2007, Pages 1946-1957

  Kowol, Christian R ^a   Eichinger, Rene ^a   Jakupec, Michael A ^a   Galanski, Mathea S ^a   Arion, Vladimir B ^a   Keppler, Bernhard K ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antitumour agents; Gallium; Ruthenium; Thiosemicarbazone; X ray diffraction

Indexed keywords

2 ACETYLPYRIDINE N,N DIMETHYLSELENOSEMICARBAZONE; 2 ACETYLPYRIDINE N,N DIMETHYLSEMICARBAZONE; 2 ACETYLPYRIDINE N,N DIMETHYLTHIOSEMICARBAZONE; 2 ACETYLPYRIDINE THIOSEMICARBAZONE; CHALCOGEN; GALLIUM; METAL ION; RUTHENIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CARBON NUCLEAR MAGNETIC RESONANCE; COMPLEX FORMATION; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; NITROGEN NUCLEAR MAGNETIC RESONANCE; OVARY CANCER; PROTON NUCLEAR MAGNETIC RESONANCE; ULTRAVIOLET SPECTROSCOPY; X RAY CRYSTALLOGRAPHY;

EID: 35348872557     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinorgbio.2007.07.026     Document Type: Article

References (37)

1. West D.X., Padhye S.B., and Sonawane P.B. Struct. Bond. 76 (1991) 1-50
2. Brockman R.W., Thomson J.R., Bell M.J., and Skipper H.E. Cancer Res. 16 (1956) 167-170
3. Moore E.C., Zedeck M.S., Agrawal K.C., and Sartorelli A.C. Biochemistry 9 (1970) 4492-4498
4. French F.A., Blanz Jr. E.J., Shaddix S.C., and Brockman R.W. J. Med. Chem. 17 (1974) 172-181
5. Shao J., Zhou B., Chu B., and Yen Y. Curr. Cancer Drug Targets 6 (2006) 409-431
6. Moore E.C., and Sartorelli A.C. Pharm. Ther. 24 (1984) 439-447
7. Chaston T.B., Lovejoy D.B., Watts R.N., and Richardson D.R. Clin. Cancer Res. 9 (2003) 402-414
8. Casas J.S., Garcia-Tasende M.S., and Sordo J. Coord. Chem. Rev. 209 (2000) 197-261
9. Kowol C.R., Berger R., Eichinger R., Roller A., Jakupec M.A., Schmidt P.P., Arion V.B., and Keppler B.K. J. Med. Chem. 50 (2007) 1254-1265
10. Vogelesang C. Recl. Trav. Chim. Pays-Bas 62 (1943) 5-11
11. Alessio E., Balducci G., Calligaris M., Costa G., Attia W.M., and Mestroni G. Inorg. Chem. 30 (1991) 609-618
12. Klayman D.L., Scovill J.P., Bartosevich J.F., and Mason C.J. J. Med. Chem. 22 (1979) 1367-1373
13. Klayman D.L., Scovill J.P., Bartosevich J.F., and Mason C.J. Eur. J. Med. Chem. 16 (1981) 317-320
14. saint-plus (Version 7.06a) and APEX2, Bruker-Nonius AXS Inc., Madison, WI, USA, 2004.
15. Sheldrick G.M. shelxs-97, Program for Crystal Structure Solution (1997), University of Göttingen, Germany
16. Sheldrick G.M. shelxl-97, Program for Crystal Structure Refinement (1997), University of Göttingen, Germany
17. C.K. Johnson, Report ORNL-5138, Oak Ridge National Laboratory, 840 Oak Ridge, TN, 1976.
18. International Tables for X-ray Crystallography, vol. C, Tables 4.2.6.8 and 6.1.1.4, Kluwer Academic Press, Dordrecht, The Netherlands, 1992.
19. Easmon J., Heinisch G., and Holzer W. Heterocycles 29 (1989) 1399-1408
20. Easmon J., Heinisch G., and Holzer W. Sci. Pharm. 61 (1993) 3-10
21. Isab A.A., Wazeer M.I.M., Fettouhi M., Ahmad S., and Ashraf W. Polyhedron 25 (2006) 2629-2636
22. Wu R., Hernandez G., Odom J.D., Dunlap R.B., and Silks L.A. Chem. Commun. 10 (1996) 1125-1126
23. Okamura T., Taniuchi K., Lee K., Yamamoto H., Ueyama N., and Nakamura A. Inorg. Chem. 45 (2006) 9374-9380
24. Kovala-Demertzi D., Domopoulou A., Demertzis M., Valdes-Martinez J., Hernandez-Ortega S., Espinosa-Perez G., West D.X., Salberg M.M., Bain G.A., and Bloom P.D. Polyhedron 15 (1996) 2587-2596
25. Naik D.V., and Palenik G.J. Acta Cryst.B. 30 (1974) 2396-2401
26. West D.X., Bain G.A., Butcher R.J., Jasinski J.P., Li Y., and Pozdniakiv R.Y. Polyhedron 15 (1996) 665-674
27. Bermejo E., Carballo R., Castiñeiras A., Dominquez R., Liberta A.E., Maichle-Mössmer C., Salberg M.M., and West D.X. Eur. J. Inorg. Chem. (1999) 965-973
28. Cambridge Structure Database, Version 5.28, November 2006.
29. West D.X., Mokijewski B.L., Gebremedhin H., and Romack T.J. Transition Met. Chem. 17 (1992) 384-386
30. Arion V.B., Jakupec M.A., Galanski M., Unfried P., and Keppler B.K. J. Inorg. Biochem. 91 (2002) 298-305
31. Grguric-Sipka S., Kowol C.R., Valiahdi S.-M., Eichinger R., Jakupec M.A., Roller A., Shova S., Arion V.B., and Keppler B.K. Eur. J. Inorg. Chem. 18 (2007) 2870-2878
32. Beer P.D., Sikanyika H., Blackburn C., McAleer J.F., and Drew M.G.B. J. Chem. Soc. Dalton Trans. (1990) 3295-3300
33. Klayman D.L., Scovill J.P., Mason C.J., Bartosevich J.F., Bruce J., and Lin A.J. Arzneim.-Forsch. 33 (1983) 909-912
34. Todorović T.R., Bacchi A., Juranić N.O., Sladić D.M., Pelizzi G., Božić T.T., Filipović N.R., and And{combining short stroke overlay}elković K.K. Polyhedron 26 (2007) 3428-3436
35. Agrawal K.C., Booth B.A., Michaud R.L., Moore E.C., and Sartorelli A.C. Biochem. Pharmacol. 23 (1974) 2421-2429
36. Bregant F., Pacor S., Ghosh S., Chattopadhyah S.K., and Sava G. Anticancer Res. 13 (1993) 1011-1017
37. Mazumder U.K., Gupta M., Karki S.S., Bhattacharya S., Rathinasamy S., and Thangavel S. Chem. Pharm. Bull. 52 (2004) 178-185